Comments

Pacira BioSciences Stock Guidance

PCRXNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$26.55
-0.13-0.51%
Last update: Dec 16, 1:05 PM
OverviewNewsEarningsOptions

Guidance

Analyst RatingsInsider TradesShort InterestGovernment TradesStock Report

Pacira BioSciences Stock Guidance | NASDAQ:PCRX | Benzinga

Pacira BioSciences issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
11/06/2025PCRX
Pacira BioSciences
FY2025———$725.00M$735.00M$736.36MGet Alert
08/05/2025PCRX
Pacira BioSciences
FY2025———$730.00M$750.00M$743.16MGet Alert
05/08/2025PCRX
Pacira BioSciences
FY2025———$725.00M$765.00M$752.89MGet Alert
02/27/2025PCRX
Pacira BioSciences
FY2025———$725.00M$765.00M$747.55MGet Alert
01/10/2025PCRX
Pacira BioSciences
FY2024———$701.00M$701.00M$695.18MGet Alert
11/06/2024PCRX
Pacira BioSciences
FY2024———$680.00M$705.00M—Get Alert
07/30/2024PCRX
Pacira BioSciences
FY2024———$680.00M$705.00M$694.66MGet Alert
05/07/2024PCRX
Pacira BioSciences
FY2024———$680.00M$705.00M$691.61MGet Alert
02/29/2024PCRX
Pacira BioSciences
FY2024———$680.00M$705.00M$722.45MGet Alert
01/04/2024PCRX
Pacira BioSciences
Q42023———$181.20M$181.20M$179.91MGet Alert
01/04/2024PCRX
Pacira BioSciences
FY2023———$675.00M$675.00M$677.30MGet Alert
01/05/2023PCRX
Pacira BioSciences
FY2022$2.50—$2.77$666.80M$666.80M$671.30MGet Alert
10/13/2022PCRX
Pacira BioSciences
Q32022———$167.50M$167.50M$172.72MGet Alert
07/14/2022PCRX
Pacira BioSciences
Q22022———$169.40M$169.40M$174.91MGet Alert
04/12/2022PCRX
Pacira BioSciences
Q12022———$157.40M$158.40M$162.85MGet Alert
01/06/2022PCRX
Pacira BioSciences
FY2021———$540.70M$541.70M$534.70MGet Alert

FAQ

Q

What is the most recent guidance for Pacira BioSciences (PCRX)?

A

There have been no specific sales or earnings guidance reported for Pacira BioSciences in recent months.

Browse guidance and forecast on all stocks.

People Also Watch

Theravance Biopharma Inc
NASDAQ:TBPH
$17.59
-1.01%
GH Research PLC
NASDAQ:GHRS
$12.24
-1.96%
Xeris Biopharma Holdings Inc
NASDAQ:XERS
$7.22
-0.35%
Rapport Therapeutics Inc
NASDAQ:RAPP
$30.06
1.55%
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
$15.06
2.48%
Alumis Inc
NASDAQ:ALMS
$11.25
-0.53%
Aquestive Therapeutics Inc
NASDAQ:AQST
$5.90
-2.79%
Esperion Therapeutics Inc
NASDAQ:ESPR
$3.68
-2.65%
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved